Midgard
U

Undbio

Gyeonggi, South Korea undbio.com From their website, Nov 2026

Work here? Claim this listing

About

UNDBIO is a pharmaceutical company that handles insulin, insulin analogues, monoclonal antibodies, general injectables, and related medical device products. Its headquarters are in Uijeongbu-si, Gyeonggi-do, and its research institute is in Suwon-si, Gyeonggi-do.

Services

  • Drug Device Combination

    It carries out co-package development with medical device products such as insulin pumps and continuous glucose monitoring systems.

  • Monoclonal antibody (mAb)

    It handles monoclonal antibody products such as adalimumab and bevacizumab.

Capabilities

Assays and studies
  • Efficacy research
  • Analytical method development
  • Quality control testing
  • Quality assurance management
Therapeutic areas
  • Diabetes
  • Cancer
  • Immune-related intractable diseases
  • Anticancer drugs
  • Genetic rare diseases

Modalities and species

Modalities
Antibody

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: global GMP-certified pharmaceutical facilities

Company

Type
CDMO
Quality
글로벌 GMP (Maintenance and management of the quality management system) · GMP (global GMP-certified pharmaceutical facilities)

Locations

Based in
Gyeonggi, South Korea
Sites
  • 의정부시, 대한민국
  • 수원시, 대한민국
Serves
Domestic, Overseas, All low-development countries worldwide

Contacts

Similar labs